Figure 2.
Emulated prospective monitoring results for myocardial infarction among initiators of rofecoxib versus initiators of non-selective non-steroidal anti-inflammatory drugs
Monitoring period 1 begins May 20, 1999, when rofecoxib prescriptions first appeared in the databases. Each monitoring period is a calendar quarter in duration.
